Fig. 7.
Fig. 7. Lysis of MMB3.19 target cells by in vitro restimulated CTLs. / (A) CD4-enriched lymph node cells from MMB3.19-primed wt,pfpo, and gld mice were restimulated in vitro with irradiated MMB3.19 cells in the presence of T-STIM. They were then used as effectors in a JAM assay with3H-TdR–labeled MMB3.19 target cells. (B) CD8-enriched splenocytes from MMB3.19-challenged wt,pfpo, and gld mice were restimulated in vitro with irradiated MMB3.19 cells in the presence of T-STIM. They were depleted of NK cells and CD4+ T cells prior to use as CTL effectors against 3H-TdR labeled MMB3.19 targets. The data are presented as the percentage of specific lysis plus or minus one standard deviation.

Lysis of MMB3.19 target cells by in vitro restimulated CTLs.

(A) CD4-enriched lymph node cells from MMB3.19-primed wt,pfpo, and gld mice were restimulated in vitro with irradiated MMB3.19 cells in the presence of T-STIM. They were then used as effectors in a JAM assay with3H-TdR–labeled MMB3.19 target cells. (B) CD8-enriched splenocytes from MMB3.19-challenged wt,pfpo, and gld mice were restimulated in vitro with irradiated MMB3.19 cells in the presence of T-STIM. They were depleted of NK cells and CD4+ T cells prior to use as CTL effectors against 3H-TdR labeled MMB3.19 targets. The data are presented as the percentage of specific lysis plus or minus one standard deviation.

Close Modal

or Create an Account

Close Modal
Close Modal